CO6900140A2 - Compuestos y composiciones como inhibidores de la quinasa c-kit - Google Patents

Compuestos y composiciones como inhibidores de la quinasa c-kit

Info

Publication number: CO6900140A2
Authority: CO; Colombia
Prior art keywords: compositions; compounds; kinase inhibitors; kit kinase; kit
Prior art date: 2011-09-01

Application number

CO14043411A

Other languages

English (en)

Inventor

Vince Yeh

Xiaolin Li

Xiaodong Liu

Jon Loren

Valentina Molteni

Juliet Nabakka

Bao Nguyen

Hank Michael James Petrassi

Original Assignee

Irm Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-09-01

Filing date

2014-02-28

Publication date

2014-03-20

2014-02-28 Application filed by Irm Llc filed Critical Irm Llc

2014-03-20 Publication of CO6900140A2 publication Critical patent/CO6900140A2/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pulmonology (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Otolaryngology (AREA)
Physical Education & Sports Medicine (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Child & Adolescent Psychology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CO14043411A 2011-09-01 2014-02-28 Compuestos y composiciones como inhibidores de la quinasa c-kit CO6900140A2 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201161530028P	2011-09-01	2011-09-01

Publications (1)

Publication Number	Publication Date
CO6900140A2 true CO6900140A2 (es)	2014-03-20

Family

ID=46829898

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CO14043411A CO6900140A2 (es)	2011-09-01	2014-02-28	Compuestos y composiciones como inhibidores de la quinasa c-kit

Country Status (41)

Country	Link
US (1)	US9199981B2 (es)
EP (1)	EP2751102B1 (es)
JP (1)	JP6117208B2 (es)
KR (1)	KR101959590B1 (es)
CN (1)	CN103764653B (es)
AP (1)	AP2014007494A0 (es)
AR (1)	AR087752A1 (es)
AU (1)	AU2012300248B2 (es)
BR (1)	BR112014004504B1 (es)
CA (1)	CA2845159C (es)
CL (1)	CL2014000494A1 (es)
CO (1)	CO6900140A2 (es)
CR (1)	CR20140106A (es)
CU (1)	CU20140023A7 (es)
CY (1)	CY1121695T1 (es)
DK (1)	DK2751102T3 (es)
EA (1)	EA024293B1 (es)
ES (1)	ES2732671T3 (es)
GT (1)	GT201400036A (es)
HR (1)	HRP20191140T1 (es)
HU (1)	HUE044373T2 (es)
IL (1)	IL231226A (es)
JO (1)	JOP20120246B1 (es)
LT (1)	LT2751102T (es)
MA (1)	MA35459B1 (es)
ME (1)	ME03395B (es)
MX (1)	MX342329B (es)
MY (1)	MY167245A (es)
PE (1)	PE20141033A1 (es)
PL (1)	PL2751102T3 (es)
PT (1)	PT2751102T (es)
RS (1)	RS59025B1 (es)
SG (1)	SG2014011050A (es)
SI (1)	SI2751102T1 (es)
TN (1)	TN2014000061A1 (es)
TR (1)	TR201909189T4 (es)
TW (1)	TWI543981B (es)
UA (1)	UA110841C2 (es)
UY (1)	UY34300A (es)
WO (1)	WO2013033070A1 (es)
ZA (1)	ZA201401113B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013033167A1 (en)	2011-09-01	2013-03-07	Irm Llc	Compounds and compositions as c-kit kinase inhibitors
UY34305A (es)	2011-09-01	2013-04-30	Novartis Ag	Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
CN104619709B (zh) *	2012-07-13	2016-11-09	Ucb生物制药私人有限公司	作为tnf活性调节剂的咪唑并吡啶衍生物
CA2897651C (en)	2013-01-10	2021-09-21	Pulmokine, Inc.	Non-selective kinase inhibitors
US9073921B2 (en)	2013-03-01	2015-07-07	Novartis Ag	Salt forms of bicyclic heterocyclic derivatives
US9925184B2 (en)	2013-10-11	2018-03-27	Pulmokine, Inc.	Spray-dry formulations
WO2015082411A1 (de) *	2013-12-05	2015-06-11	Bayer Pharma Aktiengesellschaft	Aryl- und hetaryl-substituierte imidazo[1,2-a]pyridin-3-carboxamide und ihre verwendung
CN103965190A (zh) *	2014-05-20	2014-08-06	定陶县友帮化工有限公司	一种咪唑并[1,2-a]吡啶-3-甲酸的合成方法
EA201890201A1 (ru)	2015-07-02	2018-06-29	Янссен Сайенсиз Айрлэнд Юси	Антибактериальные соединения
US10059708B2 (en) *	2016-04-26	2018-08-28	Northwestern University	Therapeutic targeting of the interleukin 1 receptor-associated kinase 4 (IRAK4) in leukemias characterized by rearrangements in the mixed lineage leukemia gene (MLL-r)
CN109415349A (zh)	2016-06-16	2019-03-01	爱尔兰詹森科学公司	杂环化合物作为抗细菌剂
AU2017286368B2 (en)	2016-06-16	2021-02-25	Janssen Sciences Ireland Unlimited Company	Heterocyclic compounds as antibacterials
RU2763525C2 (ru)	2016-10-27	2021-12-30	Пульмокин, Инк.	Комбинированная терапия для лечения легочной гипертензии
EA201991997A1 (ru)	2017-03-01	2020-01-22	Янссен Сайенсиз Айрлэнд Анлимитед Компани	Комбинированная терапия
CN111039946A (zh) *	2018-10-15	2020-04-21	上海轶诺药业有限公司	一类咪唑并芳环类化合物的制备和应用
AU2020242287A1 (en)	2019-03-21	2021-09-02	INSERM (Institut National de la Santé et de la Recherche Médicale)	A Dbait molecule in combination with kinase inhibitor for the treatment of cancer
TW202108581A (zh) *	2019-05-13	2021-03-01	瑞士商諾華公司	N-(5-(5-((1r,2s)-2氟環丙基)-1,2,4-㗁二唑-3-基)-2-甲基苯基)咪唑并[1,2-a]吡啶-3-甲醯胺之結晶型
JP2022548247A (ja)	2019-09-13	2022-11-17	ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー	抗菌化合物
WO2021089791A1 (en)	2019-11-08	2021-05-14	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en)	2020-01-22	2021-07-29	Onxeo	Novel dbait molecule and its use
BR112022017530A2 (pt) *	2020-03-17	2022-10-18	Sumitomo Pharma Co Ltd	Derivado de oxadiazol
US11767319B2 (en) *	2020-07-15	2023-09-26	Third Harmonic Bio, Inc.	Crystalline forms of a selective c-kit kinase inhibitor
JP2023551434A (ja)	2020-11-19	2023-12-08	サードハーモニックバイオ，インコーポレイテッド	選択的ｃ－ｋｉｔキナーゼ阻害剤の医薬組成物ならびにその作製および使用のための方法
US20220175740A1 (en) *	2020-11-19	2022-06-09	Novartis Ag	Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same
WO2022182982A1 (en) *	2021-02-26	2022-09-01	Third Harmonic Bio, Inc.	Methods for treating c-kit kinase mediated diseases and disorders using a selective c-kit kinase inhibitor
AU2022237769A1 (en)	2021-03-16	2023-11-02	Janssen Sciences Ireland Unlimited Company	Antibacterial compounds
AU2022236404A1 (en)	2021-03-17	2023-11-02	Janssen Sciences Ireland Unlimited Company	Antibacterial compounds
CA3211592A1 (en)	2021-03-17	2022-09-22	Jerome Emile Georges Guillemont	Antibacterial compounds
AU2022377203A1 (en)	2021-10-28	2024-06-13	Janssen Sciences Ireland Unlimited Company	Imidazopyridine amides and related compounds for use in the treatment of bacterial infections
WO2024089170A1 (en)	2022-10-27	2024-05-02	Janssen Sciences Ireland Unlimited Company	Antibacterial compounds
WO2024123966A1 (en) *	2022-12-07	2024-06-13	Third Harmonic Bio, Inc.	Compounds and compositions as c-kit kinase inhibitors
US20240254119A1 (en) *	2022-12-07	2024-08-01	Third Harmonic Bio, Inc.	COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS
WO2024223859A1 (en)	2023-04-26	2024-10-31	Janssen Pharmaceutica Nv	Antibacterial compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9518993D0 (en) *	1995-09-16	1995-11-15	Agrevo Uk Ltd	Fungicides
US20070072861A1 (en) *	2000-03-27	2007-03-29	Barbara Roniker	Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
AU2003251561A1 (en)	2002-06-20	2004-01-06	Beacon Looms, Inc.	Knitted electrical conductor fabric
JP2007524596A (ja)	2003-02-28	2007-08-30	トランスフォーム・ファーマシューティカルズ・インコーポレイテッド	共結晶医薬組成物
US7754717B2 (en)	2005-08-15	2010-07-13	Amgen Inc.	Bis-aryl amide compounds and methods of use
CA2668190A1 (en)	2006-11-03	2008-05-15	Irm Llc	Compounds and compositions as protein kinase inhibitors
BR112013012078A2 (pt) *	2010-11-15	2019-09-24	Abbvie Inc	inibidores de nampt e rock
EP2751103A1 (en) *	2011-09-01	2014-07-09	Irm Llc	Compounds and compositions as c-kit kinase inhibitors
WO2013033167A1 (en) *	2011-09-01	2013-03-07	Irm Llc	Compounds and compositions as c-kit kinase inhibitors
EP2751105A1 (en) *	2011-09-01	2014-07-09	Irm Llc	Compounds and compositions as c-kit kinase inhibitors

2012
- 2012-08-27 US US13/595,575 patent/US9199981B2/en active Active
- 2012-08-28 MX MX2014002482A patent/MX342329B/es active IP Right Grant
- 2012-08-28 CA CA2845159A patent/CA2845159C/en active Active
- 2012-08-28 PT PT12756879T patent/PT2751102T/pt unknown
- 2012-08-28 JP JP2014528513A patent/JP6117208B2/ja active Active
- 2012-08-28 PE PE2014000294A patent/PE20141033A1/es active IP Right Grant
- 2012-08-28 AP AP2014007494A patent/AP2014007494A0/xx unknown
- 2012-08-28 AU AU2012300248A patent/AU2012300248B2/en active Active
- 2012-08-28 SI SI201231624T patent/SI2751102T1/sl unknown
- 2012-08-28 MY MYPI2014000347A patent/MY167245A/en unknown
- 2012-08-28 ME MEP-2019-183A patent/ME03395B/me unknown
- 2012-08-28 TR TR2019/09189T patent/TR201909189T4/tr unknown
- 2012-08-28 UA UAA201401136A patent/UA110841C2/uk unknown
- 2012-08-28 BR BR112014004504-6A patent/BR112014004504B1/pt active IP Right Grant
- 2012-08-28 RS RS20190784A patent/RS59025B1/sr unknown
- 2012-08-28 KR KR1020147008106A patent/KR101959590B1/ko active IP Right Grant
- 2012-08-28 SG SG2014011050A patent/SG2014011050A/en unknown
- 2012-08-28 DK DK12756879.8T patent/DK2751102T3/da active
- 2012-08-28 LT LTEP12756879.8T patent/LT2751102T/lt unknown
- 2012-08-28 ES ES12756879T patent/ES2732671T3/es active Active
- 2012-08-28 CN CN201280042763.1A patent/CN103764653B/zh active Active
- 2012-08-28 HU HUE12756879 patent/HUE044373T2/hu unknown
- 2012-08-28 WO PCT/US2012/052621 patent/WO2013033070A1/en active Application Filing
- 2012-08-28 EA EA201490540A patent/EA024293B1/ru not_active IP Right Cessation
- 2012-08-28 PL PL12756879T patent/PL2751102T3/pl unknown
- 2012-08-28 EP EP12756879.8A patent/EP2751102B1/en active Active
- 2012-08-29 UY UY0001034300A patent/UY34300A/es active IP Right Grant
- 2012-08-30 JO JOP/2012/0246A patent/JOP20120246B1/ar active
- 2012-08-31 TW TW101131940A patent/TWI543981B/zh active
- 2012-08-31 AR ARP120103222A patent/AR087752A1/es active IP Right Grant
2014
- 2014-02-10 TN TNP2014000061A patent/TN2014000061A1/en unknown
- 2014-02-13 ZA ZA2014/01113A patent/ZA201401113B/en unknown
- 2014-02-27 CU CUP2014000023A patent/CU20140023A7/es unknown
- 2014-02-27 CL CL2014000494A patent/CL2014000494A1/es unknown
- 2014-02-27 GT GT201400036A patent/GT201400036A/es unknown
- 2014-02-27 IL IL231226A patent/IL231226A/en active IP Right Grant
- 2014-02-28 CO CO14043411A patent/CO6900140A2/es active IP Right Grant
- 2014-02-28 CR CR20140106A patent/CR20140106A/es unknown
- 2014-03-28 MA MA36863A patent/MA35459B1/fr unknown
2019
- 2019-06-21 HR HRP20191140TT patent/HRP20191140T1/hr unknown
- 2019-06-27 CY CY20191100671T patent/CY1121695T1/el unknown

Also Published As

Publication number	Publication date
BR112014004504B1 (pt)	2022-03-22
IL231226A0 (en)	2014-04-30
UY34300A (es)	2013-04-05
CA2845159C (en)	2020-11-03
LT2751102T (lt)	2019-07-10
ES2732671T3 (es)	2019-11-25
PE20141033A1 (es)	2014-08-30
NZ621092A (en)	2016-06-24
WO2013033070A1 (en)	2013-03-07
RS59025B1 (sr)	2019-08-30
AU2012300248A1 (en)	2014-04-17
CR20140106A (es)	2014-05-02
HUE044373T2 (hu)	2019-10-28
MX2014002482A (es)	2014-11-25
AU2012300248B2 (en)	2015-08-27
EP2751102A1 (en)	2014-07-09
CN103764653B (zh)	2015-12-02
TN2014000061A1 (en)	2015-07-01
EP2751102B1 (en)	2019-03-27
PT2751102T (pt)	2019-07-10
IL231226A (en)	2017-03-30
EA024293B1 (ru)	2016-09-30
CA2845159A1 (en)	2013-03-07
CL2014000494A1 (es)	2014-09-05
AR087752A1 (es)	2014-04-16
KR20140071382A (ko)	2014-06-11
JP6117208B2 (ja)	2017-04-19
GT201400036A (es)	2015-06-02
SG2014011050A (en)	2014-08-28
ZA201401113B (en)	2015-10-28
ME03395B (me)	2020-01-20
UA110841C2 (uk)	2016-02-25
MX342329B (es)	2016-09-26
TR201909189T4 (tr)	2019-07-22
AP2014007494A0 (en)	2014-03-31
TW201313716A (zh)	2013-04-01
US9199981B2 (en)	2015-12-01
BR112014004504A2 (pt)	2017-03-28
TWI543981B (zh)	2016-08-01
MY167245A (en)	2018-08-14
EA201490540A1 (ru)	2014-06-30
KR101959590B1 (ko)	2019-03-18
US20130059846A1 (en)	2013-03-07
PL2751102T3 (pl)	2019-09-30
HRP20191140T1 (hr)	2019-09-20
SI2751102T1 (sl)	2019-08-30
CY1121695T1 (el)	2020-07-31
DK2751102T3 (da)	2019-07-01
CN103764653A (zh)	2014-04-30
MA35459B1 (fr)	2014-09-01
CU20140023A7 (es)	2014-04-24
JP2014525444A (ja)	2014-09-29
JOP20120246B1 (ar)	2022-03-14

Publication	Publication Date	Title
CO6900141A2 (es)	2014-03-20	Compuestos y composiciones como inhibidores de la quinasa c-kit
CO6900140A2 (es)	2014-03-20	Compuestos y composiciones como inhibidores de la quinasa c-kit
HRP20181429T1 (hr)	2018-11-30	Novi derivati benzimidazola kao inhibitori kinaze
CO6831983A2 (es)	2014-01-10	Compuestos heterocíclicos como inhibidores de cinasas
CO6920291A2 (es)	2014-04-10	3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idhmutante
CO6801747A2 (es)	2013-11-29	Derivados de pirrolotriazinona como inhibidores de pi3k
CO6880068A2 (es)	2014-02-28	Aminoquinazolinas como inhibidores de quinasa
CO6970602A2 (es)	2014-06-13	Inhibidores de quinasa
BR112015002709A2 (pt)	2017-07-04	novos compostos de pirrolopirimidina como inibidores de proteínas quinases
DK2710007T3 (da)	2020-01-27	Kinasehæmmere
BRPI0908849A2 (pt)	2015-08-25	Composto e composições como c-kit e inibidores de pdgfr quinase
BR112013015449A2 (pt)	2016-09-20	compostos de bi-heteroarila como inibidores de vps23
CO6862145A2 (es)	2014-02-10	Imidazopiridazinas como inhibidores de quinasa akt
ME02576B (me)	2017-06-20	Derivati tetrahidropirolotiazina kao inhibitori bace
CO6900144A2 (es)	2014-03-20	Compuestos de triazolopiridina como inhibidores de la ped10a
EP2847186A4 (en)	2015-10-28	SUBSTITUTED AMINOCHINAZOLINES USE AS CHINESE HEMMER
CO7020914A2 (es)	2014-08-11	Nievos derivados de morofolinilo útiles como inhibidores de mogat-2
CR20130603A (es)	2014-09-09	Compuestos novedosos como inhibidores de diacilglicerol
BR112012030931A2 (pt)	2016-11-08	derivados de 2-amino-piriidina úteis como inibidores de jnk
FR2997080B1 (fr)	2015-11-27	Inhibiteurs de neprilysine
CU24069B1 (es)	2015-01-29	Compuestos de pirrolo-pirimidina como inhibidores de cdk4/6

Legal Events

Date	Code	Title	Description
2015-07-30	FG	Application granted